Bioequivalent Letermovir Usage for Prophylaxis in Haploidentical Stem Cell Transplantation at High Risk of CMV Reactivation: A Report of Two Cases From India. (PubMed, Cureus) - May 28, 2025 - "While outcomes were favorable, the small sample size and single-center experience represent limitations. Nonetheless, the findings highlight the potential benefit of extended prophylaxis beyond Day 100 and the need for individualized CMV prevention strategies in immunosuppressed populations."
Journal • Bone Marrow Transplantation • Classical Hodgkin Lymphoma • Cytomegalovirus Infection • Hematological Disorders • Hematological Malignancies • Hodgkin Lymphoma • Immunology • Infectious Disease • Lymphoma • Oncology • Primary Immunodeficiency • Transplantation
|
|
Arijit Nag; Asish Rath; Baalamurugan Kt; Debranjani Chattopadhyay; Dibakar Podder; Jeevan Kumar; Reena Nair; Rizwan Javed; Saswata Saha; Shouriyo Ghosh; Soumyadip Chatterji; Suyash Bharat
|